← Назад к работе
Работы, цитирующие эту работу
Работ: 2
Работа: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Продукты
Для разработчиков
AkademBaseОткрытый API экосистемыРабот: 2
Работа: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia